NCT01248390

Brief Summary

The purpose of this research is to see whether adding a new therapy helps people with brain injury focus better and think more clearly. You are being asked to participate in this research study because you have had a brain injury. If you decide to volunteer, you will be in the study for about six months.As a participant, you will be randomly assigned to one of 2 treatment plans. Randomization is a process like flipping a coin and means you will have a chance of being assigned to either of the plans. One group will be given an experimental therapy using a metronome one hour a day, three times a week. A metronome is a device that produces a steady beat. You will need to keep time with the metronome doing several different movements. On each beat, you will be given information both through sound and on a computer screen about whether you were early or late and how far off beat you were. The tempo of the beat will be at 54 beats per minute, so you will need to process the feedback information very quickly to adjust your speed up or down to match the beat. The various movements include things like clapping hands, tapping toes, or alternating between different similar movements. It is hoped that the metronome will help subjects to concentrate better.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 22, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 25, 2010

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
2.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 3, 2016

Completed
Last Updated

June 20, 2017

Status Verified

June 1, 2017

Enrollment Period

3.8 years

First QC Date

November 22, 2010

Last Update Submit

June 19, 2017

Conditions

Keywords

traumatic brain injurypost-concussion

Outcome Measures

Primary Outcomes (1)

  • Outcome Measure

    Determine whether IM training leads to improvements in attention and memory immediately post treatment and at six months in comparison to rehabilitation treatment as usual.

    Six Months Post Treatment

Secondary Outcomes (1)

  • Outcome Measure

    Six Months Post Treatment

Study Arms (2)

Interactive Metronome therapy

EXPERIMENTAL

Fifteen one-hour training sessions using Interactive Metronome system, in addition to treatment as usual.

Behavioral: Interactive metronome

Treatment as Usual

NO INTERVENTION

Standard of care symptom management.

Interventions

A randomized, controlled investigation into the effects of IM training on a sample of boys with attention deficit disorder showed positive results. Compared to an active control treatment, IM training improved performance on a host of measures, including attention, motor control, language processing, reading, and parental reports of improvements in the regulation of aggressive behavior.16 It should be noted that these cognitive and behavioral functions are common symptom areas in individuals surviving TBI and are likely to be especially affected in cases of blast injury

Interactive Metronome therapy

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Blast-related traumatic brain injury patients at least 3 months post injury with recovery to a Rancho los Amigos level 7 or 8 (alert and oriented).
  • Brain injury documented by at least one of the following:
  • i. loss of consciousness, post traumatic amnesia ii. alteration in mental status (dazed/confused), and/or physical evidence of iii.trauma (MRI/CT hemorrhage/contusion)
  • A diagnosis of Postconcussional Disorder or Mild Neurocognitive Disorder Due to a General Medical Condition.
  • Military or Veteran beneficiary
  • Males and females aged 18-55

You may not qualify if:

  • Current/prior (last 6 months) unstable medical condition that could affect current brain function (e.g. clear anoxic episode, cardiac arrest, current uncontrolled diabetes)
  • Status post craniectomy prior to cranioplasty (must be 90 days post cranioplasty without surgical complication)
  • Prior History of moderate to severe TBI (not including present injury).
  • Current (last 3 months) active suicidal or homicidal ideation or intent.
  • Current (last month) drug/alcohol abuse or dependence as determined by a score of 5 or higher on the Alcohol Use Disorders Identification Test Consumption (AUDIT-C)
  • Use of benzodiazepine or narcotic medications.
  • Participation in a concurrent drug or treatment trial
  • Must be physically able to complete the treatment tasks (including sensory functions).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Warrior Recovery Center

Colorado Springs, Colorado, 80913, United States

Location

Related Publications (1)

  • Nelson LA, Macdonald M, Stall C, Pazdan R. Effects of interactive metronome therapy on cognitive functioning after blast-related brain injury: a randomized controlled pilot trial. Neuropsychology. 2013 Nov;27(6):666-79. doi: 10.1037/a0034117. Epub 2013 Sep 23.

MeSH Terms

Conditions

Brain Injuries, TraumaticPost-Concussion Syndrome

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesBrain ConcussionHead Injuries, ClosedWounds, Nonpenetrating

Study Officials

  • Renee M Pazdan, MD

    United States Public Health Service

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 22, 2010

First Posted

November 25, 2010

Study Start

August 1, 2010

Primary Completion

May 1, 2014

Study Completion

October 3, 2016

Last Updated

June 20, 2017

Record last verified: 2017-06

Locations